# Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

> **NCT00854633** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Agennix** · enrollment: 120 (estimated)

## Conditions studied

- Nosocomial Infections

## Interventions

- **DRUG:** Talactoferrin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00854633
- **Lead sponsor:** Agennix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2012-03
- **Final completion:** 2012-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854633, "Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00854633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*